{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:57:31Z","timestamp":1760061451243},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"28","license":[{"start":{"date-parts":[[2017,9,9]],"date-time":"2017-09-09T00:00:00Z","timestamp":1504915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00216-017-0617-y","type":"journal-article","created":{"date-parts":[[2017,9,11]],"date-time":"2017-09-11T15:05:50Z","timestamp":1505142350000},"page":"6635-6642","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A microfluidics-based mobility shift assay to identify new inhibitors of \u03b2-secretase for Alzheimer\u2019s disease"],"prefix":"10.1007","volume":"409","author":[{"given":"Rongfeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chih","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,9]]},"reference":[{"key":"617_CR1","unstructured":"Prince M, Comas-Herrera A. Knapp M, Guerchet M, Karagiannidou, M. World Alzheimer Report 2016. Alzheimer\u2019s disease international. 2016. \nhttps:\/\/www.alz.co.uk\/research\/WorldAlzheimerReport2016.pdf\/\n\n."},{"key":"617_CR2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"Alzheimer\u2019s association","year":"2016","unstructured":"Alzheimer\u2019s association. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2016;12:459\u2013509.","journal-title":"Alzheimers Dement"},{"key":"617_CR3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.12715","volume":"130","author":"R Vassar","year":"2014","unstructured":"Vassar R, Kuhn PH, Haass C, Kennedy ME, Rajendran L, Wong PC, et al. Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects. J Neurochem. 2014;130:4\u201328.","journal-title":"J Neurochem"},{"key":"617_CR4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/nm0997-1016","volume":"3","author":"T Hartmann","year":"1997","unstructured":"Hartmann T, Bieger SC, Bruhl B, Tienari PJ, Ida N, Allsop D, et al. Distinct sites of intracellular production for Alzheimer\u2019s disease A\u03b240\/42 amyloid peptides. Nat Med. 1997;3:1016\u201320.","journal-title":"Nat Med"},{"key":"617_CR5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science"},{"key":"617_CR6","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1074\/jbc.M113.498246","volume":"289","author":"F Olsson","year":"2014","unstructured":"Olsson F, Schmidt S, Althoff V, Munter LM, Jin S, Rosqvist S, et al. Characterization of intermediate steps in amyloid beta (A\u03b2) production under near-native conditions. J Biol Chem. 2014;289:1540\u201350.","journal-title":"J Biol Chem"},{"key":"617_CR7","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3389\/fnagi.2014.00165","volume":"6","author":"KW Menting","year":"2014","unstructured":"Menting KW, Claassen JAHR. \u03b2-Secretase inhibitor; a promising novel therapeutic drug in Alzheimer\u2019s disease. Front Aging Neurosc. 2014;6:165. \nhttps:\/\/doi.org\/10.3389\/fnagi.2014.00165\n\n.","journal-title":"Front Aging Neurosc"},{"key":"617_CR8","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/C3CS60460H","volume":"43","author":"AK Ghosh","year":"2014","unstructured":"Ghosh AK, Osswald HL. BACE1 (\u03b2-secretase) inhibitors for the treatment of Alzheimer\u2019s disease. Chem Soc Rev. 2014;43:6765\u2013813.","journal-title":"Chem Soc Rev"},{"key":"617_CR9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jalz.2016.06.696","volume":"12","author":"J Cummings","year":"2016","unstructured":"Cummings J, Morstorf T, Lee G. Alzheimer\u2019s drug-development pipeline: 2016. Alzheimers Dement. 2016;12:222\u201332.","journal-title":"Alzheimers Dement"},{"key":"617_CR10","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1007\/s00216-011-4963-x","volume":"400","author":"F Mancini","year":"2011","unstructured":"Mancini F, Simone AD, Andrisano V. Beta-secretase as a target for Alzheimer\u2019s disease drug discovery: an overview of in vitro methods for characterization of inhibitors. Anal Bioanal Chem. 2011;400:1979\u201396.","journal-title":"Anal Bioanal Chem"},{"key":"617_CR11","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1074\/jbc.M109266200","volume":"277","author":"F Gruninger-Leitch","year":"2002","unstructured":"Gruninger-Leitch F, Schlatter D, Kung E, Nelbock P, Dobeli H. Substrate and inhibitor profile of BACE (\u03b2-secretase) and comparison with other mammalian aspartic proteases. J Biol Chem. 2002;277:4687\u201393.","journal-title":"J Biol Chem"},{"key":"617_CR12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00216-007-1356-2","volume":"388","author":"F Mancini","year":"2007","unstructured":"Mancini F, Naldi M, Cavrini V, Andrisano V. Multiwell fluorometric andcolorimetric microassays for the evaluation of beta-secretase (BACE-1) inhibitors. Anal Bioanal Chem. 2007;388:1175\u201383.","journal-title":"Anal Bioanal Chem"},{"key":"617_CR13","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1016\/j.bmc.2007.03.072","volume":"15","author":"F Manzenrieder","year":"2007","unstructured":"Manzenrieder F, Frank AO, Huber T, Dorner-Ciossek C, Kessler H. Synthesis and biological evaluation of phosphino dipeptide isostere inhibitor of human \u03b2-secretase (BACE1). Bioorg Med Chem. 2007;15:4136\u201343.","journal-title":"Bioorg Med Chem"},{"key":"617_CR14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0003-2697(03)00253-7","volume":"319","author":"ME Kennedy","year":"2003","unstructured":"Kennedy ME, Wang W, Song L, Lee J, Zhang L, Wong G, et al. Measuring human \u03b2-secretase (BACE1) activity using homogeneous time-resolved fluorescence. Anal Biochem. 2003;319:49\u201355.","journal-title":"Anal Biochem"},{"key":"617_CR15","doi-asserted-by":"crossref","first-page":"11567","DOI":"10.1021\/bi050932l","volume":"44","author":"MG Kornacker","year":"2005","unstructured":"Kornacker MG, Lai Z, Witmer M, Ma J, Hendrick J, Lee VG, et al. An inhibitor binding pocket distinct from the catalytic active site on human \u03b2-APP cleaving enzyme. Biochemistry. 2005;44:11567\u201373.","journal-title":"Biochemistry"},{"key":"617_CR16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpba.2009.07.012","volume":"52","author":"F Mancini","year":"2010","unstructured":"Mancini F, Andrisano V. Development of a liquid chromatographic system with fluorescent detection for \u03b2-secretase immobilized enzyme reactor on-line enzymatic studies. J Pharm Biomed Anal. 2010;52:355\u201361.","journal-title":"J Pharm Biomed Anal"},{"key":"617_CR17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpba.2012.03.006","volume":"73","author":"AD Simone","year":"2013","unstructured":"Simone AD, Mancini F, Cosconati S, Marinelli L, Pietra VL, Novellino E, et al. Human recombinant beta-secretase immobilized enzyme reactor for fast hits\u2019 selection and characterization from a virtual screening library. J Pharm Biomed Anal. 2013;73:131\u20134.","journal-title":"J Pharm Biomed Anal"},{"key":"617_CR18","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.chroma.2017.01.057","volume":"1487","author":"J Schejbal","year":"2017","unstructured":"Schejbal J, Slezackova L, Reminek R, Glatz ZA. Capillary electrophoresis-mass spectrometry based method for the screening of \u03b2-secretase inhibitors as potential Alzheimer\u2019s disease therapeutics. J Chromatogr A. 2017;1487:235\u201341.","journal-title":"J Chromatogr A"},{"key":"617_CR19","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1021\/ac303624z","volume":"85","author":"X Yi","year":"2013","unstructured":"Yi X, Hao Y, Xia N, Wang J, Quintero M, Li D, et al. Sensitive and continuous screening of inhibitors of \u03b2-site amyloid precursor protein cleaving enzyme 1 (BACE1) at single SPR chips. Anal Chem. 2013;85:3660\u20136.","journal-title":"Anal Chem"},{"key":"617_CR20","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1177\/1087057113482138","volume":"18","author":"Z Ren","year":"2013","unstructured":"Ren Z, Tam D, YZ X, Wone D, Yuan S, Sham HL, et al. Development of a novel \u03b2-secretase binding assay using the AlphaScreen platform. J Biomol Screen. 2013;18:695\u2013704.","journal-title":"J Biomol Screen"},{"key":"617_CR21","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ab.2004.04.031","volume":"332","author":"MC Lo","year":"2004","unstructured":"Lo MC, Aulabaugh A, Jin G, Cowling R, Bard J, Malamas M, et al. Evaluation of fluorescence-based thermal shift assays for hit identification in drug discovery. Anal Biochem. 2004;332:153\u20139.","journal-title":"Anal Biochem"},{"key":"617_CR22","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1126\/science.261.5123.895","volume":"261","author":"DJ Harrison","year":"1993","unstructured":"Harrison DJ, Fluri K, Seiler K, Fan Z, Effenhauser CS, Manz A. Micromachining a miniaturized capillary electrophoresis-based chemical analysis system on a chip. Science. 1993;261:895\u20137.","journal-title":"Science"},{"key":"617_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1517\/17460440903493431","volume":"5","author":"D Perrin","year":"2010","unstructured":"Perrin D, Fremaux C, Shutes A. Capillary microfluidic electrophoretic mobility shift assays: application to enzymatic assays in drug discovery. Expert Opin Drug Discov. 2010;5:51\u201363.","journal-title":"Expert Opin Drug Discov"},{"key":"617_CR24","doi-asserted-by":"crossref","unstructured":"Copeland RA. Enzymes: a practical introduction to structure, mechanism, and data analysis. 2nd ed. New York: Wiley-VCH; 2000.","DOI":"10.1002\/0471220639"},{"key":"617_CR25","doi-asserted-by":"crossref","first-page":"41245","DOI":"10.1074\/jbc.M112.409110","volume":"287","author":"F Jeppsson","year":"2012","unstructured":"Jeppsson F, Eketjall S, Janson J, Karlstrom S, Gustavsson S, Olsson LL, et al. Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease. J Biol Chem. 2012;287:41245\u201357.","journal-title":"J Biol Chem"},{"key":"617_CR26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/cpdd.130","volume":"3","author":"A Quartino","year":"2014","unstructured":"Quartino A, Huledal G, Sparve E, L\u00fcttgen M, Bueters T, Karlsson P, et al. Population pharmacokinetic and pharmacodynamic analysis of plasma A\u03b240 and A\u03b242 following single oral doses of the BACE1 inhibitor AZD3839 to healthy volunteers. Clin Pharmacol Drug Dev. 2014;3:396\u2013405.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"617_CR27","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3233\/JAD-150834","volume":"50","author":"S Eketjall","year":"2016","unstructured":"Eketjall S, Janson J, Kaspersson K, Bogstedt A, Jeppsson F, Falting J, et al. AZD3293: a novel, orally active bace1 inhibitor with high potency and permeability and markedly slow off-rate kinetics. J Alzheimers Dis. 2016;50:1109\u201323.","journal-title":"J Alzheimers Dis"},{"key":"617_CR28","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3233\/JAD-160701","volume":"55","author":"G Cebers","year":"2017","unstructured":"Cebers G, Alexander RC, Haeberlein SB, Han D, Goldwater R, Ereshefsky L, et al. AZD3293: pharmacokinetic and pharmacodynamic effects in healthy subjects and patients with Alzheimer\u2019s disease. J Alzheimers Dis. 2017;55:1039\u201353.","journal-title":"J Alzheimers Dis"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-017-0617-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-017-0617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-017-0617-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,11,3]],"date-time":"2017-11-03T16:22:52Z","timestamp":1509726172000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-017-0617-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,9]]},"references-count":28,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["617"],"URL":"https:\/\/doi.org\/10.1007\/s00216-017-0617-y","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,9]]}}}